Grail
Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.
4
Funding Rounds
$1.8b
Money raised
Overview
Grail is a biotechnology company headquartered in Menlo Park, California that was founded as a spinoff of Illumina Inc and initially headed by Jeffrey Huber in 2016, focused on making a medical device that can detect early stage cancer.
| Name | Phone | Social networks | |
|---|---|---|---|
| Je***** Ow*** | - | - | - |
| Je** Hu*** | - | - | linkedin twitter facebook |
| Al** Ar****** | - | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Bo* Ra**** | - | - | |
| Aa*** Fr***** | - | - |
Funding
Funding series
Funding Series Analysis
The company Grail has raised a total of $690m in funding over 4 rounds.
Key Insights:
- Grail Series D round, May 2020: $390m
- Grail series C funding round, May 2018: $300m
- Grail Series B round, March 2017: $900m
- Grail, Inc. funding round, December 2019: $250m
Grail Series D round, May 2020
$390m
Grail series C funding round, May 2018
$300m
Grail, Inc. funding round, December 2019
$250m
Grail Series B round, March 2017
$900m
Industries
Grail is active in the following industries:
- In-vitro diagnostics (IVD)
- Healthcare
- Diagnostic tools
- Cancer
- Oncology
- Biomedical engineering
- Technology
- Biology
- Biotechnology
- Internal medicine
- Medicine
- Pharmaceutical industry
- Engineering